This topic contains a solution. Click here to go to the answer

Author Question: The client is receiving warfarin (Coumadin). Which laboratory result will the nurse monitor to ... (Read 91 times)

arivle123

  • Hero Member
  • *****
  • Posts: 569
The client is receiving warfarin (Coumadin). Which laboratory result will the nurse monitor to evaluate the therapeutic response?
 
  1. WBC
  2. PT and INR
  3. BNP
  4. aPTT

Question 2

The client is receiving heparin (Hep-Lock). The nurse will monitor which laboratory results to evaluate therapeutic response?
 
  1. INR
  2. aPTT
  3. BNP
  4. PT



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

izzat

  • Sr. Member
  • ****
  • Posts: 328
Answer to Question 1

2

Rationale 1: WBC is used to determine infection.
Rationale 2: PT and INR should be monitored for a client receiving warfarin (Coumadin) therapy.
Rationale 3:BNP is incorrect because this lab result does not pertain to clotting.
Rationale 4:aPTT is incorrect because this should be monitored for a client receiving heparin therapy.

Global Rationale: PT and INR should be monitored for a client receiving warfarin (Coumadin) therapy. PT is incorrect because it should be monitored with INR for a client receiving warfarin (Coumadin) therapy. BNP is incorrect because this lab result does not pertain to clotting. aPTT is incorrect because this should be monitored for a client receiving heparin therapy.

Answer to Question 2

2

Rationale 1:INR is incorrect because it should be monitored for a client receiving warfarin (Coumadin) therapy.
Rationale 2: To avoid serious adverse effects, drug therapy with coagulation-modifier drugs is individualized to each patient and must be carefully monitored. For heparin, the activated partial thromboplastin time (aPTT) is used.
Rationale 3: BNP or beta natriuretic peptide is used for the severity rate of congestive heart failure.
Rationale 4:PT is incorrect because it should be monitored for a client receiving warfarin (Coumadin) therapy.

Global Rationale: To avoid serious adverse effects, drug therapy with coagulation-modifier drugs is individualized to each patient, and must be carefully monitored. For heparin, the activated partial thromboplastin time (aPTT) is used. PT and INRare incorrect because they should be monitored for a client receiving warfarin (Coumadin) therapy. BNP is incorrect because this lab result does not pertain to clotting.




arivle123

  • Member
  • Posts: 569
Reply 2 on: Jul 23, 2018
:D TYSM


apple

  • Member
  • Posts: 352
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Asthma occurs in one in 11 children and in one in 12 adults. African Americans and Latinos have a higher risk for developing asthma than other groups.

Did you know?

The average adult has about 21 square feet of skin.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

Did you know?

Not getting enough sleep can greatly weaken the immune system. Lack of sleep makes you more likely to catch a cold, or more difficult to fight off an infection.

Did you know?

Sperm cells are so tiny that 400 to 500 million (400,000,000–500,000,000) of them fit onto 1 tsp.

For a complete list of videos, visit our video library